GFS Advisors’s AstraZeneca AZN Stock Holding History

GFS Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,800	Closed	-$222K	–	122
2018 Q3	$222K	Sell	2,800 -4,250	-60%	-$321K	0.06%	123
2018 Q2	$495K	Hold	7,050	–	–	0.1%	111
2018 Q1	$493K	Sell	7,050 -4,613	-40%	-$320K	0.1%	110
2017 Q4	$809K	Sell	11,663 -3,950	-25%	-$266K	0.18%	89
2017 Q3	$1.06M	Sell	15,613 -5,204	-25%	-$329K	0.24%	79
2017 Q2	$1.42M	Sell	20,817 -4,415	-17%	-$288K	0.31%	62
2017 Q1	$1.57M	Buy	+25,232	New	+$1.47M	0.32%	59

Other funds holding AZN

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return